The DE-CTR ACCEL Program funds pilot clinical and translational research to improve Delaware health outcomes and support future NIH grant competitiveness, with a focus on community engagement and underserved populations.
Funder: DE-CTR ACCEL Program
Due Dates (Anticipated): January 2027 (Preliminary Application) | May 2027 (Full Application)
Funding Amounts: Up to $100,000 direct costs per award; Regular Pilots: 1 year | Community Engagement Pilots: 18 months
Summary: Supports clinical and translational research projects to improve health outcomes in Delaware and build competitiveness for future NIH funding.
Key Information: Preliminary application is required before full submission; only ACCEL partner institution faculty are eligible as PI.
This program provides short-term, pilot funding for clinical and translational research projects that aim to improve health outcomes for Delawareans. The initiative supports both Regular and Community Engagement pilot projects, helping teams generate preliminary data and develop collaborations necessary for future independent external funding, particularly from the NIH. The program emphasizes bridging laboratory discoveries to patient care or community health and prioritizes projects addressing medically underserved populations and junior investigators.